Education
About Us
Working with TipRanks
Follow Us
UG Healthcare Corp. Ltd. (SG:8K7)
SGX:8K7
8K7 Stock Chart & Stats
S$0.10
>-S$0.01(-3.23%)
At close: 4:00 PM EST
S$0.10
>-S$0.01(-3.23%)
Day’s Range― - ―
52-Week RangeS$0.09 - S$0.12
Previous CloseN/A
Volume145.10K
Average Volume (3M)131.00K
Market Cap
S$58.02M
Enterprise ValueS$82.08M
Total Cash (Recent Filing)S$45.13M
Total Debt (Recent Filing)S$28.46M
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding623,825,800
10 Day Avg. Volume276,890
30 Day Avg. Volume131,003
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)0.43
Price to Sales (P/S)0.47
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained 51.8% annual revenue expansion indicates durable end-market demand for disposable gloves and infection‑prevention products. Robust top-line growth improves scale economics, supports utilization of manufacturing capacity across markets, and underpins potential margin recovery if cost control follows.
Relatively Conservative LeverageLow leverage and a strong equity base provide structural financial stability and optionality. A 0.30 debt/equity ratio with 68% equity ratio reduces refinancing risk, limits interest burden, and gives capacity to fund capex or weather demand cyclicality without aggressive external financing.
Positive Free Cash Flow To Income RatioA FCF-to-net-income ratio above 1.0 suggests the business can convert accounting losses into cash under current operations. If sustained, this supports reinvestment, working capital needs and reduces dependence on equity/debt raises, strengthening long-term self-financing capability.
Bears Say
Negative Profitability MarginsNegative margins and ROE reflect structural difficulty converting strong sales into shareholder returns, likely from high operating costs, input cost pressure or pricing limits. Persistent low profitability constrains retained earnings, weakens ability to fund growth, and limits investor returns.
Sharply Deteriorating Cash GenerationA steep decline in FCF growth and negative operating cash flow versus net income signal worsening liquidity conversion. Continued cash erosion reduces headroom for working capital, capex and debt service, potentially forcing higher-cost financing or asset sales if trends persist.
Loss-making And EPS CollapseNegative EPS growth and a negative P/E indicate the company is loss-making, which structurally limits access to equity and debt markets on favorable terms. Persistent losses hinder strategic investment, restrict dividend capacity and can impair long-term competitiveness if not reversed.
UG Healthcare Corp. Ltd. News
8K7 FAQ
What was UG Healthcare Corp. Ltd.’s price range in the past 12 months?
UG Healthcare Corp. Ltd. lowest share price was S$0.09 and its highest was S$0.12 in the past 12 months.
What is UG Healthcare Corp. Ltd.’s market cap?
UG Healthcare Corp. Ltd.’s market cap is S$58.02M.
When is UG Healthcare Corp. Ltd.’s upcoming earnings report date?
UG Healthcare Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 188 days.
How were UG Healthcare Corp. Ltd.’s earnings last quarter?
UG Healthcare Corp. Ltd. released its earnings results on Feb 11, 2026. The company reported -S$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.002.
Is UG Healthcare Corp. Ltd. overvalued?
According to Wall Street analysts UG Healthcare Corp. Ltd.’s price is currently Overvalued.
Does UG Healthcare Corp. Ltd. pay dividends?
UG Healthcare Corp. Ltd. pays a Notavailable dividend of S$0.003 which represents an annual dividend yield of N/A. See more information on UG Healthcare Corp. Ltd. dividends here
What is UG Healthcare Corp. Ltd.’s EPS estimate?
UG Healthcare Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does UG Healthcare Corp. Ltd. have?
UG Healthcare Corp. Ltd. has 623,825,800 shares outstanding.
What happened to UG Healthcare Corp. Ltd.’s price movement after its last earnings report?
UG Healthcare Corp. Ltd. reported an EPS of -S$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of UG Healthcare Corp. Ltd.?
Currently, no hedge funds are holding shares in SG:8K7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UG Healthcare Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-2.33%
Trailing 12-Months
Asset Growth
4.43%
Trailing 12-Months
Company Description
UG Healthcare Corp. Ltd.
UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing essential products to hospitals, clinics, and healthcare providers worldwide. With a commitment to quality and innovation, UG Healthcare has established a strong reputation for its nitrile and latex gloves, catering to both the medical and industrial sectors.
Technical Analysis
Riverstone Holdings
―
Hyphens Pharma International Ltd.
―
Medtecs International Corporation Ltd.
―
Pharmesis International Ltd.
―
―